학술논문
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Document Type
Article
Author
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 2023, 13)
Subject
Language
English
ISSN
2234943X